Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc.

DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management: Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY 10577 31s t March 2026 **See disclaimers at end of letter** Dear Members of the Board, Management and Fellow Stakeholders, Pineal Capital Management (“We”), the Advisor to Pineal Capital Fund 1 (the ‘'Fund''), is a special opportunities investment advisor, seeking deep-value opportunities within secular growth markets, with a specific focus on companies that are under-owned, under-researched and underperforming. Pineal Capital Fund 1 is a shareholder in Teladoc Health (“Teladoc” or the “Company”).